- Reuters•3 hours ago
The following are mergers under review by the European Commission and a brief guide to the EU merger process: APPROVALS AND WITHDRAWALS None NEW LISTINGS -- German furniture and household goods retailer ...
- The Wall Street Journal•10 hours ago
European central banks are looking to corporate debt to help get the region’s economy firing on all cylinders again, but many companies are wary of investing the proceeds from those purchases.
Regeneron (REGN) and partner Sanofi's atopic dermatitis treatment, dupilumab, is under priority review in the U.S. A response should be out by Mar 29, 2017.
Paris - Paris Delayed Price. Currency in EUR
|Bid||71.12 x 1000|
|Ask||71.74 x 44000|
|Day's Range||67.39 - 68.61|
|52wk Range||24.83 - 93.82|
|1y Target Est||N/A|
|P/E Ratio (ttm)||21.13|
|Avg Vol (3m)||9,729|
|Dividend & Yield||N/A (N/A)|